Ingevity (NGVT) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

NGVT Stock Forecast

Ingevity stock forecast is as follows: an average price target of $47.00 (represents a 15.20% upside from NGVT’s last price of $40.80) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

NGVT Price Target

The average price target for Ingevity (NGVT) is $47.00 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $47.00 to $47.00. This represents a potential 15.20% upside from NGVT's last price of $40.80.

NGVT Analyst Ratings

Buy

According to 4 Wall Street analysts, Ingevity's rating consensus is 'Buy'. The analyst rating breakdown for NGVT stock is 0 'Strong Buy' (0.00%), 2 'Buy' (50.00%), 2 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Ingevity Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Oct 31, 2024	John McNulty	BMO Capital	$47.00	$41.79	12.47%	15.20%
Aug 05, 2024	John McNulty	BMO Capital	$42.00	$35.63	17.88%	2.94%
Jul 10, 2024	John McNulty	BMO Capital	$45.00	$40.62	10.78%	10.29%
May 07, 2024	Chris Kapsch	Loop Capital Markets	$56.00	$53.85	3.99%	37.25%
Apr 22, 2024	Daniel Rizzo	Jefferies	$62.00	$44.44	39.51%	51.96%
Feb 02, 2023	Christopher Kapsch	Loop Capital Markets	$100.00	$87.00	14.94%	145.10%

The latest Ingevity stock forecast, released on Oct 31, 2024 by John McNulty from BMO Capital, set a price target of $47.00, which represents a 12.47% increase from the stock price at the time of the forecast ($41.79), and a 15.20% increase from NGVT last price ($40.80).

Ingevity Price Target by Period

	1M	3M	12M
# Anlaysts	-	1	5
Avg Price Target	-	$47.00	$50.40
Last Closing Price	$40.80	$40.80	$40.80
Upside/Downside	-100.00%	15.20%	23.53%

In the current month, the average price target of Ingevity stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Ingevity's last price of $40.80. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 07, 2024	CJS Securities		Outperform	Upgrade
Aug 05, 2024	BMO Capital	Market Perform	Market Perform	Hold
Jul 10, 2024	BMO Capital	Market Perform	Market Perform	Hold
May 07, 2024	Loop Capital Markets	Hold	Hold	Hold
May 02, 2024	Oppenheimer	Outperform	Outperform	Hold
Aug 07, 2023	BMO Capital		Perform	Downgrade
Jul 27, 2023	Loop Capital Markets		Buy	Upgrade

Ingevity's last stock rating was published by CJS Securities on Aug 07, 2024. The company Upgrade its NGVT rating from "null" to "Outperform".

Ingevity Financial Forecast

Ingevity Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$446.00M	$481.80M	$392.60M	$383.60M	$482.00M	$419.90M	$382.80M	$336.00M	$376.80M	$358.40M	$320.30M	$325.60M	$331.70M	$270.60M	$288.20M	$303.40M	$359.90M
Avg Forecast	$323.59M	$404.07M	$420.85M	$322.13M	$327.33M	$400.63M	$409.40M	$320.80M	$310.80M	$376.95M	$407.58M	$319.15M	$332.72M	$464.28M	$486.43M	$411.22M	$392.90M	$422.62M	$409.67M	$341.58M	$289.44M	$354.29M	$337.64M	$291.78M	$282.63M	$317.02M	$256.30M	$264.74M	$305.50M	$365.40M
High Forecast	$353.51M	$441.44M	$459.76M	$351.92M	$357.60M	$437.68M	$447.25M	$357.00M	$333.00M	$411.81M	$445.27M	$319.18M	$340.19M	$490.00M	$531.41M	$449.24M	$429.23M	$422.62M	$409.67M	$341.58M	$289.44M	$354.29M	$337.64M	$291.78M	$282.63M	$317.02M	$256.30M	$264.74M	$305.50M	$365.40M
Low Forecast	$305.76M	$381.81M	$397.66M	$304.38M	$309.30M	$378.56M	$386.84M	$299.40M	$297.40M	$356.18M	$385.12M	$319.12M	$325.25M	$448.00M	$459.63M	$388.56M	$371.25M	$422.62M	$409.67M	$341.58M	$289.44M	$354.29M	$337.64M	$291.78M	$282.63M	$317.02M	$256.30M	$264.74M	$305.50M	$365.40M
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	2	6	3	3	4	4	4	4	3	3	3	3	3	7	7	9	8	6
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.96%	0.99%	0.95%	0.98%	1.14%	1.02%	1.12%	1.16%	1.06%	1.06%	1.10%	1.15%	1.05%	1.06%	1.09%	0.99%	0.98%

Ingevity's average Quarter revenue forecast for Dec 23 based on 2 analysts is $332.72M, with a low forecast of $325.25M, and a high forecast of $340.19M. NGVT's average Quarter revenue forecast represents a -25.40% decrease compared to the company's last Quarter revenue of $446.00M (Sep 23).

Ingevity EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	2	6	3	3	4	4	4	4	3	3	3	3	3	7	7	9	8	6
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$89.00M	$101.30M	$122.30M	$73.20M	$138.20M	$121.10M	$117.90M	$77.90M	$31.20M	$113.90M	$101.80M	$106.90M	$122.90M	$60.70M	$91.90M	$97.00M	$111.00M
Avg Forecast	$83.81M	$104.66M	$109.00M	$83.44M	$84.78M	$103.77M	$106.04M	$83.09M	$80.50M	$97.63M	$105.57M	$79.62M	$86.18M	$120.25M	$125.99M	$72.38M	$98.54M	$117.74M	$114.13M	$57.22M	$80.64M	$98.70M	$94.06M	$78.08M	$78.74M	$88.32M	$71.40M	$60.65M	$85.11M	$101.80M
High Forecast	$91.56M	$114.34M	$119.08M	$91.15M	$92.62M	$113.36M	$115.84M	$92.47M	$86.25M	$106.66M	$115.33M	$95.54M	$88.11M	$126.92M	$137.64M	$86.86M	$118.25M	$117.74M	$114.13M	$68.66M	$80.64M	$98.70M	$94.06M	$93.70M	$78.74M	$88.32M	$71.40M	$72.78M	$85.11M	$101.80M
Low Forecast	$79.20M	$98.89M	$103.00M	$78.84M	$80.11M	$98.05M	$100.20M	$77.55M	$77.03M	$92.26M	$99.75M	$63.69M	$84.24M	$116.04M	$119.05M	$57.90M	$78.83M	$117.74M	$114.13M	$45.77M	$80.64M	$98.70M	$94.06M	$62.46M	$78.74M	$88.32M	$71.40M	$48.52M	$85.11M	$101.80M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.74%	0.80%	1.69%	0.74%	1.17%	1.06%	2.06%	0.97%	0.32%	1.21%	1.30%	1.36%	1.39%	0.85%	1.52%	1.14%	1.09%

2 analysts predict NGVT's average Quarter EBITDA for Dec 23 to be $86.18M, with a high of $88.11M and a low of $84.24M. This is -3.17% lower than Ingevity's previous annual EBITDA (Sep 23) of $89.00M.

Ingevity Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	2	6	3	3	4	4	4	4	3	3	3	3	3	7	7	9	8	6
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$25.20M	$35.50M	$50.70M	$15.60M	$75.40M	$59.80M	$60.80M	$29.30M	$-4.20M	$44.30M	$48.70M	$46.00M	$69.90M	$20.20M	$45.30M	$44.30M	$59.90M
Avg Forecast	$32.31M	$70.06M	$73.69M	$29.77M	$30.02M	$49.91M	$49.04M	$26.21M	$9.21M	$32.02M	$38.26M	$41.16M	$-3.46M	$44.08M	$49.83M	$37.42M	$37.06M	$61.52M	$58.97M	$29.58M	$28.16M	$55.96M	$47.92M	$37.35M	$28.19M	$36.87M	$21.92M	$29.90M	$36.53M	$51.35M
High Forecast	$36.19M	$78.48M	$82.55M	$33.34M	$33.63M	$55.91M	$54.93M	$31.98M	$10.31M	$32.34M	$42.86M	$49.40M	$798.55K	$50.63M	$55.83M	$44.90M	$44.48M	$61.52M	$58.97M	$35.50M	$28.16M	$55.96M	$47.92M	$44.82M	$28.19M	$36.87M	$21.92M	$35.88M	$36.53M	$51.35M
Low Forecast	$29.99M	$65.04M	$68.41M	$27.63M	$27.87M	$46.34M	$45.52M	$20.69M	$8.55M	$31.69M	$35.52M	$32.93M	$-6.65M	$40.07M	$46.27M	$29.94M	$29.65M	$61.52M	$58.97M	$23.67M	$28.16M	$55.96M	$47.92M	$29.88M	$28.19M	$36.87M	$21.92M	$23.92M	$36.53M	$51.35M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.57%	0.71%	1.35%	0.42%	1.23%	1.01%	2.06%	1.04%	-0.08%	0.92%	1.30%	1.63%	1.90%	0.92%	1.52%	1.21%	1.17%

Ingevity's average Quarter net income forecast for Dec 23 is $-3.46M, with a range of $-6.65M to $798.55K. NGVT's average Quarter net income forecast represents a -113.73% decrease compared to the company's last Quarter net income of $25.20M (Sep 23).

Ingevity SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	2	6	3	3	4	4	4	4	3	3	3	3	3	7	7	9	8	6
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$40.00M	$51.70M	$48.60M	$55.90M	$54.20M	$48.70M	$40.00M	$48.30M	$43.50M	$47.50M	$40.00M	$41.50M	$34.90M	$34.50M	$38.50M	$40.80M	$40.70M
Avg Forecast	$39.19M	$48.94M	$50.97M	$39.02M	$39.65M	$48.52M	$49.59M	$38.85M	$37.64M	$45.66M	$49.36M	$27.08M	$40.30M	$56.23M	$58.92M	$24.62M	$61.10M	$49.09M	$47.59M	$19.46M	$33.62M	$41.15M	$39.22M	$30.68M	$32.83M	$36.82M	$29.77M	$25.41M	$35.49M	$42.44M
High Forecast	$42.82M	$53.47M	$55.68M	$42.62M	$43.31M	$53.01M	$54.17M	$43.24M	$40.33M	$49.88M	$53.93M	$32.50M	$41.20M	$59.35M	$64.36M	$29.54M	$73.32M	$49.09M	$47.59M	$23.35M	$33.62M	$41.15M	$39.22M	$36.82M	$32.83M	$36.82M	$29.77M	$30.49M	$35.49M	$42.44M
Low Forecast	$37.03M	$46.24M	$48.16M	$36.87M	$37.46M	$45.85M	$46.85M	$36.26M	$36.02M	$43.14M	$46.64M	$21.66M	$39.39M	$54.26M	$55.67M	$19.70M	$48.88M	$49.09M	$47.59M	$15.57M	$33.62M	$41.15M	$39.22M	$24.54M	$32.83M	$36.82M	$29.77M	$20.33M	$35.49M	$42.44M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.71%	0.88%	1.97%	0.91%	1.10%	1.02%	2.06%	1.44%	1.06%	1.21%	1.30%	1.26%	0.95%	1.16%	1.52%	1.15%	0.96%

Ingevity's average Quarter SG&A projection for Dec 23 is $40.30M, based on 2 Wall Street analysts, with a range of $39.39M to $41.20M. The forecast indicates a 0.74% rise compared to NGVT last annual SG&A of $40.00M (Sep 23).

Ingevity EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	3	1	1	1	2	6	3	3	4	4	4	4	3	3	3	3	3	7	7	9	8	6
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$0.70	$0.98	$1.36	$0.42	$1.99	$1.55	$1.56	$0.75	$-0.11	$1.11	$1.21	$1.24	$1.69	$0.49	$1.09	$1.06	$1.42
Avg Forecast	$0.89	$1.93	$2.03	$0.82	$0.83	$1.38	$1.35	$0.72	$0.25	$0.88	$1.05	$0.34	$-0.10	$1.21	$1.37	$1.13	$0.87	$1.69	$1.62	$1.04	$0.78	$1.54	$1.32	$1.03	$0.78	$1.01	$0.60	$0.80	$1.01	$1.41
High Forecast	$1.00	$2.16	$2.27	$0.92	$0.93	$1.54	$1.51	$0.88	$0.28	$0.89	$1.18	$0.38	$0.02	$1.39	$1.54	$1.27	$0.97	$1.69	$1.62	$1.04	$0.78	$1.54	$1.32	$1.03	$0.78	$1.01	$0.60	$0.80	$1.01	$1.41
Low Forecast	$0.83	$1.79	$1.88	$0.76	$0.77	$1.28	$1.25	$0.57	$0.24	$0.87	$0.98	$0.31	$-0.18	$1.10	$1.27	$1.05	$0.80	$1.69	$1.62	$1.04	$0.78	$1.54	$1.32	$1.03	$0.78	$1.01	$0.60	$0.80	$1.01	$1.41
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.58%	0.71%	1.20%	0.49%	1.18%	0.96%	1.51%	0.97%	-0.07%	0.84%	1.17%	1.60%	1.67%	0.81%	1.35%	1.05%	1.00%

According to 2 Wall Street analysts, Ingevity's projected average Quarter EPS for Dec 23 is $-0.10, with a low estimate of $-0.18 and a high estimate of $0.02. This represents a -113.62% decrease compared to NGVT previous annual EPS of $0.70 (Sep 23).

Ingevity Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
OEC	Orion Engineered Carbons	$16.82	$32.00	90.25%	Buy
ESI	Element Solutions	$26.71	$40.00	49.76%	Buy
KWR	Quaker Chemical	$148.04	$192.50	30.03%	Buy
ECVT	Ecovyst	$7.52	$9.50	26.33%	Buy
FUL	H.B. Fuller Company	$71.97	$85.60	18.94%	Buy
MTX	Minerals	$78.82	$90.00	14.18%	Buy
SXT	Sensient	$76.46	$85.00	11.17%
NGVT	Ingevity	$43.40	$47.00	8.29%	Buy

NGVT Forecast FAQ

Is Ingevity a good buy?

Yes, according to 4 Wall Street analysts, Ingevity (NGVT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 50.00% of NGVT's total ratings.

What is NGVT's price target?

Ingevity (NGVT) average price target is $47 with a range of $47 to $47, implying a 15.20% from its last price of $40.8. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Ingevity stock go up soon?

According to Wall Street analysts' prediction for NGVT stock, the company can go up by 15.20% (from the last price of $40.8 to the average price target of $47), up by 15.20% based on the highest stock price target, and up by 15.20% based on the lowest stock price target.

Can Ingevity stock reach $60?

NGVT's average twelve months analyst stock price target of $47 does not support the claim that Ingevity can reach $60 in the near future.

What are Ingevity's analysts' financial forecasts?

Ingevity's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.46B (high $1.6B, low $1.37B), average EBITDA is $377.68M (high $414.29M, low $355.9M), average net income is $155.18M (high $176.45M, low $140.43M), average SG&A $176.61M (high $193.73M, low $166.43M), and average EPS is $4.27 (high $4.86, low $3.87). NGVT's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.47B (high $1.61B, low $1.39B), average EBITDA is $380.91M (high $416.13M, low $359.92M), average net income is $205.82M (high $230.56M, low $191.08M), average SG&A $178.12M (high $194.59M, low $168.31M), and average EPS is $5.67 (high $6.35, low $5.26).

Did the NGVT's actual financial results beat the analysts' financial forecasts?

Based on Ingevity's last annual report (Dec 2022), the company's revenue was $1.67B, beating the average analysts forecast of $1.57B by 6.48%. Apple's EBITDA was $451.5M, beating the average prediction of $387.63M by 16.48%. The company's net income was $211.6M, beating the average estimation of $187.13M by 13.07%. Apple's SG&A was $198.8M, beating the average forecast of $177.24M by 12.17%. Lastly, the company's EPS was $5.54, beating the average prediction of $5.22 by 6.17%. In terms of the last quarterly report (Sep 2023), Ingevity's revenue was $446M, missing the average analysts' forecast of $464.28M by -3.94%. The company's EBITDA was $89M, missing the average prediction of $120.25M by -25.99%. Ingevity's net income was $25.2M, missing the average estimation of $44.08M by -42.83%. The company's SG&A was $40M, missing the average forecast of $56.23M by -28.87%. Lastly, the company's EPS was $0.7, missing the average prediction of $1.21 by -42.35%